Pathkey.Ai Ltd Appoints Former Altium Chairman and Launches $2.8M Placement

Pathkey.AI's $2.8M placement cornerstoned by Sam Weiss — the man who chaired Altium through its A$9.1 billion Renesas acquisition — signals serious semiconductor ambitions for ASX-listed PKY and its AI chip design platform Chipforge.
By Josua Ferreira -
  • Sam Weiss, who chaired Altium through its A$9.1 billion acquisition by Renesas Electronics, has joined Pathkey.AI as a strategic advisor and cornerstoned a $2.8 million placement at $0.028 per share.
  • The placement will issue 100,000,000 new shares, with settlement on 19 August 2026 and allotment expected on or around 20 August 2026, lifting the trading halt applied from 12 August 2026.
  • Chipforge, PKY's AI-native chip design and verification platform, has already secured its first commercial contract — a US$50,000 fixed-fee FPGA engagement with an Australian industrial automation company signed ahead of general release.
  • Weiss's 40,000,000 performance rights vest in equal tranches at 6, 12, 24 and 36 months, structuring his incentives around multi-year delivery rather than a short-term advisory arrangement.
  • Proceeds will be directed toward accelerating Chipforge's technology, marketing and business development, with the platform targeting a global semiconductor market forecast to reach approximately US$1 trillion by 2030.

Pathkey.AI appoints Altium’s former chairman and launches $2.8M placement to accelerate Chipforge

Pathkey.AI Ltd (ASX: PKY) has appointed Sam Weiss, former Non-Executive Chairman of Altium Limited, as a strategic advisor and received firm commitments for a $2.8 million placement that Weiss cornerstoned.

The dual development links the company to an A$9.1 billion technology exit. Weiss oversaw Altium’s growth to a ~A$9.1 billion cash acquisition by Renesas Electronics, and is now backing PKY’s adjacent semiconductor play, Chipforge.

A marquee advisor with a A$9.1 billion track record

Weiss served as Non-Executive Chairman of ASX-listed Altium Limited from 2007 to 2024. Over that period, he oversaw the company’s rise from a small Sydney-based software firm to a global leader in printed circuit board design software.

His chairmanship culminated in the acquisition of Altium by Japanese semiconductor firm Renesas Electronics for approximately A$9.1 billion in cash. For PKY, the appointment signals credibility and networks aligned with Chipforge’s ambitions in the semiconductor design market.

Weiss’s credentials include:

  • Non-Executive Chairman, Altium Limited (2007–2024)

  • Oversaw growth to global electronic design automation (EDA) leadership

  • Chairmanship culminated in the ~A$9.1B Renesas acquisition

Why Chipforge sits in Altium’s adjacent market

Altium demonstrated that an Australian-originated, engineer-centric design platform could capture global leadership in electronic design automation (EDA), a category long dominated by US incumbents Cadence and Mentor Graphics.

Chipforge sits in the directly adjacent semiconductor design market. It is described as an AI-native chip design and verification platform covering FPGA and ASIC targets, running an end-to-end flow from design intent through generated register transfer level (RTL) code, verification, simulation and sign-off.

In simpler terms, Chipforge applies AI automation to the process of designing computer chips, from the initial concept through to the final checks before production. According to the company, it targets FPGA and ASIC workflows that remain fragmented and talent-constrained.

The strategic thesis is that the convergence of design software and silicon that drove Renesas to acquire Altium is the same convergence Chipforge is built to capture. Chipforge Pte. Ltd. is incorporated in Singapore and forms part of the PKY Group.

The Chipforge acquisition terms structured consideration as 560,000,000 shares at A$0.022 each alongside 150,000,000 milestone-linked performance rights, with Chipforge holding an exclusive worldwide licence from Nanyang Technological University’s Ntuitive Pte Ltd targeting a global semiconductor market forecast to reach approximately US$1 trillion by 2030.

Inside the $2.8 million strategic placement

The company advised receipt of firm commitments to raise $2,800,000 (before costs) through a strategic placement to institutional and sophisticated investors, cornerstoned by Sam Weiss.

A total of 100,000,000 new fully paid ordinary shares will be issued at $0.028 per share. Shares under the placement will settle on 19 August 2026 and are expected to be allotted on or around 20 August 2026. All securities will be issued under the company’s existing placement capacity available under ASX Listing Rules 7.1 and 7.1A.

Placement Detail Figure
Amount raised (before costs) $2.8 million
Shares issued 100,000,000
Issue price $0.028
Settlement date 19 August 2026
Expected allotment On or around 20 August 2026

As part of his engagement, Weiss’s incentives are structured to align with long-term performance:

  1. Weiss will be issued 40,000,000 performance rights under the company’s incentive plan.

  2. These vest in equal tranches after 6, 12, 24 and 36 months of service.

$2.8M Placement and Advisory Deal Structure

On the transaction costs, Joint Lead Managers Blue Ocean Equities, 708 Capital and Sandton Capital are entitled to a 6% Lead Manager Fee on all funds raised. Blue Ocean will also act as book runner and receive 10,000,000 unlisted options at a $0.05 exercise price, expiring 17 December 2027, for its role in managing the placement.

The announcement lifts the trading halt applied at the commencement of trading on Wednesday, 12 August 2026.

The strategic logic that drove Renesas to acquire Altium at a A$9.1 billion valuation was the convergence of design software and silicon, and that is the same convergence Chipforge is built to capture.

Where the funds are headed

The company advised that proceeds will be deployed strategically to support PKY’s growth objectives. The funds are intended to be used to:

  • Accelerate technology, marketing and business development of Chipforge

  • Support business development programs for existing assets

  • Strengthen commercial initiatives

  • Provide general working capital

The placement supports PKY’s dual-platform model. The company operates TrialKey, focused on clinical trial design and optimisation, alongside Chipforge, its AI-powered chip design platform. Both are built around an agent-based AI architecture that combines large-language-model functionality with neuro-symbolic reasoning to address complex design optimisation problems.

What comes next for PKY investors

Near-term catalysts centre on the placement settlement and allotment scheduled for 19–20 August 2026, followed by accelerated development of Chipforge.

The Chipforge first commercial contract, a US$50,000 fixed-fee FPGA design engagement with an Australian industrial automation company signed ahead of general platform release, pulled forward the commercialisation timeline and provided an early signal on product-market fit in the Asia Pacific enterprise segment.

Weiss’s multi-year engagement includes performance rights vesting out to 36 months. For investors, the appointment ties PKY’s semiconductor ambitions to an advisor with direct experience of a A$9.1 billion EDA exit, though execution against the company’s stated objectives remains ahead.

Don’t Miss the Next ASX Tech Breakout

Big News Blast delivers FREE breaking ASX tech news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button at StockWire X to get started today.


Frequently Asked Questions

Who is Sam Weiss and why is his appointment significant for Pathkey.AI?

Sam Weiss served as Non-Executive Chairman of ASX-listed Altium Limited from 2007 to 2024, overseeing its growth into a global electronic design automation leader that was acquired by Renesas Electronics for approximately A$9.1 billion. His appointment as strategic advisor to Pathkey.AI and his decision to cornerstone the $2.8 million placement links PKY's Chipforge platform to direct experience of a major EDA exit.

What is Chipforge and what does it do?

Chipforge is an AI-native chip design and verification platform developed by Pathkey.AI that covers FPGA and ASIC targets, running an end-to-end workflow from design intent through generated RTL code, verification, simulation and sign-off. It holds an exclusive worldwide licence from Nanyang Technological University and targets semiconductor design workflows that remain fragmented and talent-constrained.

What are the terms of the Pathkey.AI $2.8 million placement?

Pathkey.AI is issuing 100,000,000 new fully paid ordinary shares at $0.028 each to raise $2.8 million before costs, with settlement scheduled for 19 August 2026 and allotment expected on or around 20 August 2026. Joint Lead Managers Blue Ocean Equities, 708 Capital and Sandton Capital are entitled to a 6% fee on funds raised.

How will Pathkey.AI use the proceeds from the placement?

The company intends to use the $2.8 million raised to accelerate technology, marketing and business development of Chipforge, support business development for existing assets including TrialKey, strengthen commercial initiatives, and provide general working capital.

Has Chipforge signed any commercial contracts yet?

Yes — Chipforge signed a US$50,000 fixed-fee FPGA design engagement with an Australian industrial automation company ahead of its general platform release, providing an early commercial signal in the Asia Pacific enterprise segment before the broader product launch.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher